We used the Kasumi-3 model to study HCMV latency and reactivation in 27 myeloid progenitor cells. Kasumi-3 cells were infected with HCMV strain TB40/Ewt-GFP, flow 28 sorted for GFP+ cells, and cultured for various times to monitor establishment of latency, as 29 judged by repression of viral gene expression (RNA/DNA ratio) and loss of virus production. 30
ABSTRACT:
We used the Kasumi-3 model to study HCMV latency and reactivation in 27 myeloid progenitor cells. Kasumi-3 cells were infected with HCMV strain TB40/Ewt-GFP, flow 28 sorted for GFP+ cells, and cultured for various times to monitor establishment of latency, as 29 judged by repression of viral gene expression (RNA/DNA ratio) and loss of virus production. 30 We found that latency was established post-transcriptionally: transcription was initially turned 31 on, and then turned off. We did not find evidence to support a latency model in which viral 32 gene expression is repressed at the outset of infection. The pattern of expression of lytic genes 33 that have been associated with latency, including UL138, US28, and RNA2.7, was the same as 34 that of other lytic genes, indicating that there was no preferential expression of these genes in 35 latency. By analyzing expression of the progenitor cell marker CD34 as well as myeloid cell 36 differentiation markers in IE+ cells after treatment with TNF-α, we showed that TNF-α induced 37 reactivation independently of differentiation. In contrast, LPS did not induce reactivation in 38
Kasumi-3 cells, despite activation of ERK and NF-κB, and did not induce transcription of 39 inflammatory cytokines. We speculate that reactivation occurs in two steps: 1. activation of 40 signal-specific transcription factors that bind to the MIEP; 2. reconfiguration of viral chromatin 41 to allow access to the MIEP. We propose that differentiation is required to render cellular 42 chromatin competent to express inflammatory cytokines that drive reactivation in response to 43 LPS, but it is not required for reactivation in response to TNF-α itself. 44 45 IMPORTANCE: HCMV is an important human pathogen that establishes lifelong latent 46 infection in myeloid progenitor cells, and reactivates frequently to cause significant disease in 47 immunocompromised people. The epigenetic mechanisms that allow the virus to establish 48 latency specifically in myeloid cells, and to reactivate in response to inflammatory mediators are 49 not well understood. Our observation that viral gene expression is first turned on, and then 50 turned off to establish latency suggests that there is a host defense, which may be myeloid-51 specific, responsible for transcriptional silencing of viral gene expression. Our observation that 52 TNF-α induces reactivation independently of differentiation, but LPS does not, provides insight 53 into molecular mechanisms that control reactivation. 54 55 INTRODUCTION5 lytic replication, and that they support a latent infection (11) (12) (13) (14) (15) (16) . Cell type-specific 79 establishment of latency is thought to be due to a combination of host and viral factors. Infection 80 activates a host intrinsic immune response, which recognizes viral DNA invading the nucleus 81
and silences viral gene expression at the outset of infection through heterochromatinization of 82 viral genomes (13, (17) (18) (19) (20) (21) (22) (23) (24) (25) . Factors present in the viral particle, including the tegument protein 83 pp71, enter the cell upon infection, and counteract this host defense response to activate viral 84 gene expression. In cells that support latency, pp71 is sequestered in the cytoplasm and is 85 therefore unable to perform this function (26) (27) (28) . Differentiation of myeloid cells to a dendritic 86 cell phenotype increases permissiveness of these cells to infection and also induces reactivation 87 of both naturally and experimentally latently infected cells (12, 13, 15, 20, (29) (30) (31) (32) . Thus, the 88 generally accepted paradigm is that myeloid progenitor cells are not permissive to infection due 89 to heterochromatinization and transcriptional repression of invading viral genomes. The process 90 of myeloid cell differentiation is thought to change the balance of repressive and activating 91 cellular factors that control both viral and cellular transcription, resulting in changes to the viral 92 epigenome that activate viral gene expression (17, 33, 34) . 93
However, some observations suggest that the current paradigm may be in need of 94 revision. First, several investigators have demonstrated that, although myeloid progenitors may 95 be less permissive than other cell types, some expression of viral lytic genes is detectable at early 96 times post-infection in various models of latency, including primary CD34+ HPCs, Kasumi-3 97 cells, a CD34+ myeloblastic cell line derived from a patient with acute myeloid leukemia (AML) 98 (35) , which has recently been demonstrated to be a tractable model for CMV latency and 99 reactivation (26, 36), and primary CD14+ peripheral blood mononuclear cells (11, 12, (36) (37) (38) (39) (40) . 100
Expression of these genes is lost as latency is established. These observations suggest that 101 12 whether LPS signaling pathways were intact in Kasumi-3 cells. LPS signaling is mediated by 241 TLR4 and the co-receptor MD2 (62). CD14 acts as a chaperone to transfer LPS from LBP (LPS-242 binding protein) to its receptor. TLR4 receptor engagement activates MyD88-dependent 243 signaling, leading to activation of NF-κB and MAPKs, including ERKs, and expression of TNF-244 α, 64) . Kasumi-3 cells express TLR4 and MD-2 on the cell surface, but not 245 CD14. CD14 is required for response to low concentrations of LPS, but not for response to the 246 concentrations used in this study (65), and downstream signaling components, including NF-κB 247 and ERK, were activated in response to LPS (Fig. 6D, E) . However, analysis of RNA expression 248
showed that there was no increase in TNF-α RNA in Kasumi-3 in response to LPS (Fig. 6F) . 249
Thus, production of TNF-α in response to LPS is blocked in Kasumi-3 cells at the level of 250 transcription. Similarly, LPS did not induce expression of IL-1β or IL-6 in Kasumi-3 cells (Fig.  251 6G,H). 252
253

DISCUSSION 254
Mechanisms of establishment of latency. HCMV establishes latency in myeloid 255 progenitor cells through heterochromatinization and repression of viral gene expression, but the 256 timing and molecular mechanisms that control this process are not well understood. While some 257 studies have shown that viral gene expression is silenced immediately after infection (13, 19, 20, 258 28, 43) , others have shown that viral gene expression is activated at early times post-infection, 259
and that latency is subsequently established in this population of cells (11, 36, 38) . Our studies 260 are in agreement with this latter observation, and we show that, not only is there a decrease in the 261 abundance of viral transcripts, but that the ratio of viral RNA to DNA decreases over the course 262 of infection, and therefore that viral genomes are increasingly repressed as latency is established. 263 13 Post-transcriptional establishment of latency has also been demonstrated in some, but not all 264 HSV-infected neurons in mice (66-68). We therefore considered the possibility that there may 265 be two routes to establishment of latency: repression prior to activation of gene expression as 266 well as post-transcriptional repression. Our results show that there is heterogeneity in the 267 kinetics of viral gene expression, and that activation of the early and late phases of viral gene 268 expression is delayed in some cells, but we do not find evidence to support establishment of 269 latency at the outset of infection. Previous studies have shown that initiation of HCMV gene 270 expression requires that the cells be in the G0 or G1 phase of the cell cycle (69), and 271 heterogeneity in cell cycle phase may account for some of the observed variation in the kinetics 272 of gene expression. 273
Our findings have two important implications. First, the observation that viral gene is 274 expression is first turned on, and then turned off, suggests that there is a cellular defense 275 mechanism for shutting off viral genomes that are actively engaged in transcription. Cell type 276 specific expression of this host defense response may account for the highly restricted tropism 277 for HCMV latency. Second, shedding of HCMV is often observed in healthy, immunocompetent 278 individuals, suggesting that the virus reactivates with high frequency (70). The finding that 279 HCMV establishes latency in cells following activation of transcription raises the possibility that 280 these genomes may retain a memory of prior activation, and may therefore be poised to 281 reactivate readily under the appropriate conditions. Interestingly, previous studies have shown 282 that HCMV chromatin is specifically marked by H3 lysine 4 methylation following replication of 283 viral DNA in fibroblasts (71). It is interesting to speculate that there may be cell type-specific 284 differences in histone modifications bound to post-replicative viral DNA that affect the potential 285 to establish latency and to reactivate. 286 14 Viral transcription in latency. Several studies have suggested that some viral genes 287 that are expressed during lytic infection also have a role in latency, including UL138 and US28, 288 and genetic analyses have shown that mutation of these genes increases viral gene expression in 289 myeloid progenitor cells (40, 43, (47) (48) (49) (50) (51) . These studies did not include analyses of the 290 RNA/DNA ratio to demonstrate differences in transcriptional activity between lytic genes and 291 latency-associated lytic genes (12, 14, 40, 43, 48, 72, 73) . We have investigated expression of 292 US28, UL138, as well as the non-coding RNA2.7 in the Kasumi-3 model. We find that the 293 pattern of expression of these genes parallels that of other lytic genes, including UL122, UL123, 294 UL54, and UL32, and analysis of the RNA/DNA ratio shows that transcription of all of these 295 genes is repressed in latency. 296
The advent of highly sensitive new technologies has allowed unbiased transcriptome 297 analyses to detect viral transcripts in both experimental and natural latency. These studies have 298 identified many genes expressed under conditions of latency, and none of these show specific 299 expression of some RNAs in the absence of all other lytic genes (11, 37, 52, 54, 74) . These 300 observations raise the possibility that detection of lytic transcripts is due to the presence of a 301 small number of productively infected cells. This notion is consistent with frequent shedding of 302 virus and inflation of a CMV-specific effector memory T cell response, an indicator of repeated 303 antigen stimulation, observed in healthy individuals (70, 75) . 304
Collectively, our studies and those of others suggest that the criteria for classification of a 305 gene as latency-associated should be expanded to include analysis of relative transcriptional 306 activity, as well as quantitative analysis of RNA abundance and the effect of genetic mutation on 307 viral gene expression. 308
What is the role of myeloid cell differentiation in reactivation of HCMV? Previous 309 studies using primary CD34-derived or monocyte-derived dendritic cells (MoDCs) showed that 310 reactivation of latent HCMV carried in myeloid progenitor cells required differentiation to a 311 dendritic cell phenotype (9, 13, 20, 30, 32, 72, 76) . Reactivation in immature dendritic cells in 312 response to LPS occurred through induction of IL-6 and activation of ERKs and mitogen and 313 stress-activated kinases (MSK) (72, 77) . However, the factors that were used to differentiate 314 dendritic cells in these models are also mediators of inflammation, and it is therefore difficult to 315 distinguish the roles of a general inflammatory response from dendritic cell-specific 316 differentiation in reactivation of HCMV in these cells. In contrast, Kasumi-3 cells, like many 317 transformed cell lines, are refractory to the normal cues that induce differentiation, and are 318 therefore more suitable for studies seeking to dissect the roles of these different processes. Our 319 studies show that differentiation is not required for reactivation in response to In contrast to TNF, LPS was not able to induce reactivation in Kasumi-3 cells, despite the 321 fact that LPS induces expression of inflammatory cytokines, including TNF-α, IL-1β, and IL-6 322 in monocytic cells (63, 64) . To explain this surprising result, we investigated expression of the 323 LPS signaling components and the response of Kasumi-3 cells to LPS. We found that Kasumi-3 324 cells express the LPS co-receptors TLR4 and MD2 on the cell surface. They do not express the 325 LPS chaperone protein CD14, which is required for a response to low concentrations of LPS, but 326 is not required for the concentrations used in this study (65), and downstream signaling 327 components, including NF-κB and ERK, were activated in response to LPS. Thus, the LPS 328 signaling pathways leading to activation of transcription factors that control expression of 329 inflammatory cytokines appear to be intact in these cells. However, activation of NF-κB was not 330 sufficient to induce expression of TNFα, IL-1β, or IL-6 in response to LPS in Previous studies have shown that treatment with LPS induces selective activation of NF-κB-332 responsive genes in myeloid cells, and this differential response is governed in part by 333 chromatin-mediated restriction in access of NF-κB to its binding sites in the promoters of target 334 genes (78-81). These observations suggest that the promoter regions of cytokine genes are not 335 accessible in Kasumi-3 cells, and NF-κB is therefore not able to bind to its cognate sites to 336 activate transcription of the cytokines that drive reactivation in response to LPS. 337
Recent studies have begun to elucidate the molecular pathways for determination of 338 various lineages in the hematopoietic system (79, 82, 83) . Cell type-specific activation of gene 339 expression is achieved through chromatin remodeling of enhancers by lineage-specific pioneer 340 transcription factors, which are able to recognize their cognate binding sites in the context of 341 nucleosome-dense heterochromatin (84). Expression of these factors in committed cells opens 342 the chromatin to create nucleosome-free promoter regions that permit binding of signal-specific 343 transcription factors, such as NF-κB, and thus, cell type-specific activation of gene expression. 344
It is known that the viral genome is heterochromatinized in latently infected cells, and that 345 reactivation is associated with reprogramming of the viral epigenome (13, 20) . We hypothesize 346 that this requires both activation of signal-specific transcription factors that bind to the MIEP, 347 such as NF-κB, and remodeling of the viral chromatin to allow these transcription factors access 348 to their binding sites. We speculate that TNF-α is able to perform both of these functions, but 349 while LPS is able to activate NF-κB, it is not able to induce chromatin remodeling. 350
Differentiation of the cells may be required to perform this function. 351
Further studies will be required to fully understand the roles of differentiation, 352 inflammation, and chromatin remodeling in reactivation of HCMV. Our studies suggest that the 353 requirement for differentiation in reactivation is dependent on the context-it is not required for 354 reactivation in response to TNF-α or activation of ATM (39), but it may be required for 355 expression of myeloid lineage-specific pioneer transcription factors that mediate changes in the 356 chromatin needed to render latently infected cells competent to respond to other ligands, such as 357
LPS. 358
MATERIALS AND METHODS 359
Cells and reagents: Kasumi-3, MRC-5, and THP-1 cells were obtained from the ATCC and 360 cultured as recommended. Human recombinant TNF-α was obtained from PreproTech (#300-361 01A) and LPS was obtained from Sigma (#L5658). Fluorescent conjugated monoclonal 362 antibodies used in this study are listed in Table 1 . TB40/Ewt-GFP (36) viral stocks were 363 produced by electroporation of BAC DNA into MRC-5 fibroblasts with pGCN-pp71 expression 364 vector (85). Culture media was collected, cleared of cellular debris by centrifugation and 365 concentrated by ultracentrifugation on a sorbitol cushion (86). Viral titers were determined using 366 the 50% tissue culture infective dose (TCID 50 ) limiting dilution assay after two weeks in culture 367
Titers were calculated from duplicate 96-well plates by scoring the GFP+ wells using the method 368 of Reed and Muench (87) . 369
370
Infection of Kasumi-3 cells: Kasumi-3 cells were infected with HCMV strain TB40/Ewt-GFP at 371 high concentration (2x10 7 cells/ml) using an MOI of 1.5-2 and centrifugal enhancement of 372 infection (1000xg for 30 minutes at 25°C). Cells were then diluted to 1.25x10 6 cells/ml with fresh 373 media without removing the virus and incubated at 37°C for additional 23 hours. 1 day post-374 infection (dpi), extracellular virus was inactivated by a treatment with a Citric Acid solution as 375 previously described (38) and GFP+ and GFP-cells were sorted on a FACSAria-6 laser cell 376 sorter flow cytometer (BD Biosciences). Infected cells were cultured for 13 days to establish 377 latency, with media changes every 2-3 days. For reactivation studies, cells were treated with 378 5ng/ml TNF-α or 100ng/ml LPS at 14 dpi for 3 days at 37°C. A TCID 50 assay was used to 379 determine the infectious titer of the infected cell supernatants. 380 LPS and TNF-α treatments: Kasumi-3 cells were seeded at 6.6x10 5 cells/ml and treated with 381 5ng/ml TNF-α or 100ng/ml LPS for 4 hours. As positive control, THP-1 cells were treated or not 382 with LPS at the same conditions. Production of human TNF-α in the supernatants was analyzed 383 Real time PCR analysis. For all analyses, mock-infected cells were analyzed in parallel with 391 infected cells. These samples were uniformly positive for cellular genes, but negative for viral 392 genes. TaqMan assays specific for viral genes were custom-designed by Life Technologies 393 (Table 1) . Relative viral DNA quantity was analyzed by the ∆∆Ct method, using a pre-designed 394 assay for RNaseP as the normalization control (Life Technologies, catalog number 4403326). 395
This method was validated by determining that the efficiencies of the target and reference genes 396 were approximately equal, as described in the Supplementary Methods and shown in Fig. S3 (88) . 397
Relative viral RNA quantity was analyzed by the ∆∆Ct method using GAPDH (assay ID 398 cytometer and analyzed using FlowJo software (version 9). For the phospho-protein analysis, the 418 fraction of activated cells in each population was determined using the following formula as 419 previously described (91, 93) 420 values (C T viral gene -C T RNaseP) for each dilution were calculated and plotted against the log 798 ng DNA. The slopes of these plots were <0.1 (Fig. S3) . Similar analyses were performed to 799 demonstrate the validity of the ∆∆Ct method to quantify viral RNAs using GAPDH as the 800 normalization control. Serial dilutions of cDNA prepared from lytically infected MRC-5 cells 801 were used as the template (Fig. S5) . 802
Validation of flow cytometric analysis of phospho-Erk and phospho-NFkB (p65). Phospho-803
Erk antibody staining was validated by analyzing phorbol 12-myristate 13-acetate (PMA)-804 induced phosphorylation in Jurkat cells. Cells were either untreated or treated with 50nM PMA 805 for 15 minutes, or with the MEK inhibitor U0126 (100uM) at 37 o C followed by immediate 806 fixation with 4% methanol free formaldehyde, followed by 80% methanol permeabilization. 807 U0126 is a highly selective inhibitor of both MEK1 and MEK2. Following fix-permeabilization 808 the cells were washed and stained. One set of tubes were stained with pre-titered volume of 809
Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) rabbit mAb and the second set 810 stained with matched Isotype control (Fig. S6A) . In addition, dose-response and kinetic analyses 811 were used to evaluate activation of phospho-Erk in response to PMA. Similarly phospho-p65 812 (NFkB) antibody staining was validated by TNF-a-induced NFkB phosphorylation of HeLa cells. 813
HeLa cells were either untreated or treated with 100 nM Calyculin A, an inhibitor of protein 814 phosphatase 1 (PP1) and protein phosphatase 2A (PP2A-C) for 10 minutes followed by 20ng/ml 815 of human TNF-a for 5 minutes at 37 o C, followed by immediate fixation and permeabilization. 816
Following these, the cells were washed, and processed for staining. One set of tubes was stained 817 with pre-titered volume of phospho-NF-kB p65 (Ser563) (93H1) rabbit mAb and the second set 818 stained with matched Isotype control (Fig. S6B) . RT-qPCR and qPCR, respectively, at various times post-infection as described in Fig. 1 and  824 Materials and Methods. 825 GFP+ infected cells were purified by flow cytometry at 1 dpi. On day 14, latently infected cells were treated with TNF-α for 3 days to induce reactivation. B) Representative FACS analysis of GFP expression in Kasumi-3 infected cells at 1 dpi compared to uninfected cells. C) Release of viral particles into the media was measured by a TCID50 assay on MRC-5 cells after 2 weeks. D) UL122 mRNA expression and DNA amount were analyzed by at the indicated times post infection and expressed relative to D1 after normalization to GAPDH or RNAseP. E) RNA/DNA ratios of UL123, UL54, and UL32 over the course of infection. For Panels C to E, statistical significance was calculated by a one-way ANOVA with a Dunnett's multiple comparison test (n=4). The error bars represent standard error of the mean (SEM) and the asterisks indicate p-values (* P≤ 0.05; ** P≤ 0.01; *** P≤ 0.001; **** P ≤ 0.0001) calculated by the comparison to the peak (D4 for RNA, D8 for DNA and virus, and D1 for the RNA/DNA ratio). 
